This action requires you to be registered with Frontiers and logged in. To register or login click here.
Please indicate why this content is being reported:
Your message has been sent to the Frontiers Administration Office and will be deal with as soon as possible.
Conference
Start Time:10 Oct 2019, 11:30 AM
End Time:12 Oct 2019, 12:45 PM
Where:Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor Gama Pinto, Lisbon, Portugal
The Portuguese Society for Stem Cells and Cell Therapy (SPCE-TC) stimulates the innovation in stem cell research and technologies as well as the clinical translational of stem cell-based therapies to the benefit of human health. The main goal of the 11th International Meeting of the SPCE-TC is to gather high quality researchers coming from academia, health care institutions and industry to discuss the new trends and challenges on the emerging field of stem cell biology and cell-based therapy. The meeting also aims at giving the unique opportunity for younger researchers to network, to exchange ideas and to be inspired by top-level keynote speakers and invited opinion leaders in a truly international environment.
More specifically, the Scientific Program encompasses the current understanding of stem cell reprogramming and advancements in cancer stem cell research, tissue engineering, stem cell transplantation, manipulation of the stem cell genome in a research context, and current trends in regenerative medicine. The meeting will be organized in 5 topics: stem cell specification and regulation, stem cell engineering, stem cells in disease modelling and drug discovery, stem cells in cancer and cell therapy. Concomitant sessions dedicated to clinical translation will also be included and round-table sessions will offer the opportunity to informally debate issues such as, bioethical implications of stem cell usage.
Organizers: Susana Solá, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal, Joana Miranda, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
Speakers: Alessandro Prigione, MDC, Berlin, Germany, David Hay, University of Edinburgh, Edinburgh, United Kingdom. José Silva, Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom. Catarina Homem, CEDOC - NOVA Medical School, Lisbon, Portugal. Margarida Diogo, IBB, Instituto Superior Tecnico, Universidade de Lisboa, Lisbon, Portugal. Márcia Rodrigues, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, Guimarães, Portugal. Edgar Gomes, iMM, Faculty of Medicine, Universidade de Lisboa, Lisboa, Portugal. Alexandra Marques, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, Guimarães, Portugal. Bruno Silva-Santos, iMM, Faculty of Medicine, Universidade de Lisboa, Lisboa, Portugal. Margarida Serra, iBET, Oeiras, Portugal. Lino Ferreira, CNC, University of Coimbra, Coimbra, Portugal.
Health Science > Bioengineering and Biotechnology > Biomaterials Science > Bioengineering and Biotechnology > Stem Cell Research Science > Cell and Developmental Biology > Stem Cell Research Science > Genetics > Stem Cell Research Science > Cell and Developmental Biology > Stem Cell Treatments Science > Bioengineering and Biotechnology > Stem Cell Treatments Science > Cell and Developmental Biology > Cell Adhesion and Migration Science > Cell and Developmental Biology > Cell Differentiation and Reprogramming Science > Bioengineering and Biotechnology > Biomolecular Engineering
Keywords: Stem Cell Specification and Regulation, Stem cell engineering, Stem Cells in Disease Modelling and Drug Discovery, Stem Cells in Cancer, Cell therapies, Emerging Clinical Technologies
Posted on: 07 Jun 2019 Posted by: Susana Solá
You are in
Biomaterials
Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.